Phase I/II first-in-man trial of CYT 007 TNF Qb in patients with plaque psoriasis.
Phase of Trial: Phase I/II
Latest Information Update: 18 Aug 2011
At a glance
- Drugs CYT 007 TNFQb (Primary)
- Indications Plaque psoriasis
- Focus Adverse reactions; Therapeutic Use
- Sponsors Cytos Biotechnology
- 31 May 2007 New trial record.